Operated by Nexus Health Solutions LLC. The doctor-patient relationship is with the Wasef Health and Beluga Health physician networks, with Harper Meds as the facilitator.
The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.
General
Async telehealth with a prescription decision typically within 12 hours, and 24/7 doctor messaging.